Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.

Naismith RT, Wolinsky JS, Wundes A, LaGanke C, Arnold DL, Obradovic D, Freedman MS, Gudesblatt M, Ziemssen T, Kandinov B, Bidollari I, Lopez-Bresnahan M, Nangia N, Rezendes D, Yang L, Chen H, Liu S, Hanna J, Miller C, Leigh-Pemberton R.

Mult Scler. 2019 Nov 4:1352458519881761. doi: 10.1177/1352458519881761. [Epub ahead of print]

PMID:
31680631
2.

Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Wojcik CM, Beier M, Costello K, DeLuca J, Feinstein A, Goverover Y, Gudesblatt M, Jaworski M 3rd, Kalb R, Kostich L, LaRocca NG, Rodgers JD, Benedict RH; National MS Society Cognition Work Team.

Mult Scler. 2019 Dec;25(14):1848-1869. doi: 10.1177/1352458519879094. Epub 2019 Oct 22.

3.

Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.

Golan D, Wilken J, Doniger GM, Fratto T, Kane R, Srinivasan J, Zarif M, Bumstead B, Buhse M, Fafard L, Topalli I, Gudesblatt M.

Mult Scler Relat Disord. 2019 May;30:154-162. doi: 10.1016/j.msard.2019.01.051. Epub 2019 Jan 30.

PMID:
30772674
4.

Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.

Gudesblatt M, Wissemann K, Zarif M, Bumstead B, Fafard L, Wilken J, Blitz K, Buhse M, Santra S, Hotermans C, Lee L.

CNS Drugs. 2018 Dec;32(12):1183. doi: 10.1007/s40263-018-0574-9.

5.

Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.

Gudesblatt M, Wissemann K, Zarif M, Bumstead B, Fafard L, Wilken J, Blitz K, Buhse M, Santra S, Hotermans C, Lee L.

CNS Drugs. 2018 Dec;32(12):1173-1181. doi: 10.1007/s40263-018-0553-1. Erratum in: CNS Drugs. 2018 Sep 22;:.

6.

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Cohen JA, Hunter SF, Brown TR, Gudesblatt M, Thrower BW, Llorens L, Souza-Prien CJ, Ruby AE, Chernoff DN, Patni R.

Mult Scler. 2019 Apr;25(4):601-609. doi: 10.1177/1352458518754716. Epub 2018 Jan 25.

PMID:
29368539
7.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352. Erratum in: JAMA Neurol. 2018 Jan 1;75(1):133.

8.

The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.

Golan D, Doniger GM, Wissemann K, Zarif M, Bumstead B, Buhse M, Fafard L, Lavi I, Wilken J, Gudesblatt M.

Mult Scler. 2018 Feb;24(2):196-204. doi: 10.1177/1352458517695470. Epub 2017 Feb 1.

PMID:
28273778
9.

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater P.

Int J MS Care. 2016 Jul-Aug;18(4):177-82. doi: 10.7224/1537-2073.2015-033.

10.

Best Practices for Intrathecal Baclofen Therapy: Screening Test.

Boster AL, Bennett SE, Bilsky GS, Gudesblatt M, Koelbel SF, McManus M, Saulino M.

Neuromodulation. 2016 Aug;19(6):616-22. doi: 10.1111/ner.12437. Epub 2016 Jul 19. Review.

PMID:
27434115
11.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

12.

First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.

Hughes B, Cascione M, Freedman MS, Agius M, Kantor D, Gudesblatt M, Goldstick LP, Agashivala N, Schofield L, McCague K, Hashmonay R, Barbato L; EPOC study investigators.

Mult Scler Relat Disord. 2014 Sep;3(5):620-8. doi: 10.1016/j.msard.2014.06.006. Epub 2014 Jul 3.

PMID:
26265274
13.

The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis.

Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater PA.

Mult Scler J Exp Transl Clin. 2015 Apr 24;1:2055217315577828. doi: 10.1177/2055217315577828. eCollection 2015 Jan-Dec.

14.

Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis for Patients With Chronic Stroke.

Bethoux F, Rogers HL, Nolan KJ, Abrams GM, Annaswamy T, Brandstater M, Browne B, Burnfield JM, Feng W, Freed MJ, Geis C, Greenberg J, Gudesblatt M, Ikramuddin F, Jayaraman A, Kautz SA, Lutsep HL, Madhavan S, Meilahn J, Pease WS, Rao N, Seetharama S, Sethi P, Turk MA, Wallis RA, Kufta C.

Neurorehabil Neural Repair. 2015 Nov-Dec;29(10):911-22. doi: 10.1177/1545968315570325. Epub 2015 Feb 4.

PMID:
25653225
15.

The effects of peroneal nerve functional electrical stimulation versus ankle-foot orthosis in patients with chronic stroke: a randomized controlled trial.

Bethoux F, Rogers HL, Nolan KJ, Abrams GM, Annaswamy TM, Brandstater M, Browne B, Burnfield JM, Feng W, Freed MJ, Geis C, Greenberg J, Gudesblatt M, Ikramuddin F, Jayaraman A, Kautz SA, Lutsep HL, Madhavan S, Meilahn J, Pease WS, Rao N, Seetharama S, Sethi P, Turk MA, Wallis RA, Kufta C.

Neurorehabil Neural Repair. 2014 Sep;28(7):688-97. doi: 10.1177/1545968314521007. Epub 2014 Feb 13.

PMID:
24526708
16.

Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.

Wilken J, Kane RL, Sullivan CL, Gudesblatt M, Lucas S, Fallis R, You X, Foulds P.

Int J MS Care. 2013 Fall;15(3):120-8. doi: 10.7224/1537-2073.2012-043.

17.

Peripheral neurostimulation for the treatment of refractory cluster headache, long-term follow-up: case report.

Mammis A, Gudesblatt M, Mogilner AY.

Neuromodulation. 2011 Sep-Oct;14(5):432-5; discussion 435. doi: 10.1111/j.1525-1403.2011.00386.x. Epub 2011 Aug 19.

PMID:
21854497
18.

Intrathecal baclofen in multiple sclerosis: too little, too late?

Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M.

Mult Scler. 2011 May;17(5):623-9. doi: 10.1177/1352458510395056. Epub 2011 Jan 31. Review.

PMID:
21282321
19.

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D.

Lancet Neurol. 2010 Feb;9(2):149-58. doi: 10.1016/S1474-4422(10)70002-8. Epub 2010 Jan 8.

20.

Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease.

Mentis MJ, Delalot D, Naqvi H, Gordon MF, Gudesblatt M, Edwards C, Donatelli L, Dhawan V, Eidelberg D.

Mov Disord. 2006 Apr;21(4):549-55.

21.

Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation lead. Case report.

Alterman RL, Shils JL, Gudesblatt M, Tagliati M.

Neurosurg Focus. 2004 Jul 15;17(1):E6.

PMID:
15264775
22.

Hexosaminidase A activity and amyotrophic lateral sclerosis.

Gudesblatt M, Ludman MD, Cohen JA, Desnick RJ, Chester S, Grabowski GA, Caroscio JT.

Muscle Nerve. 1988 Mar;11(3):227-30.

PMID:
2965300
23.

Truncal ataxia presumably due to malignant spinal cord compression.

Gudesblatt M, Cohen JA, Gerber O, Sacher M.

Ann Neurol. 1987 May;21(5):511-2. No abstract available.

PMID:
3592642
24.

[Quasi-normal cerebrospinal fluid in patients with acquired immunodeficiency syndrome and cryptococcal meningitis].

Gudesblatt M, Gerber O, Vaillancourt PD, Bronster D.

Rev Neurol (Paris). 1987;143(4):290-3. French.

PMID:
3629077
25.

A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.

Caroscio JT, Cohen JA, Zawodniak J, Takai V, Shapiro A, Blaustein S, Mulvihill MN, Loucas SP, Gudesblatt M, Rube D, et al.

Neurology. 1986 Feb;36(2):141-5.

PMID:
3080693
26.

Bilateral paramedian thalamic infarctions: a CT study.

Gerber O, Gudesblatt M.

Neuroradiology. 1986;28(2):128-31.

PMID:
3703234
27.

Autonomic neuropathy associated with autoimmune disease.

Gudesblatt M, Goodman AD, Rubenstein AE, Bender AN, Choi HS.

Neurology. 1985 Feb;35(2):261-4.

PMID:
3969218
28.

Cholangiocarcinoma presenting as a cerebellar metastasis: case report and review of the literature.

Gudesblatt MS, Sencer W, Sacher M, Lanzieri CF, Song SK.

J Comput Tomogr. 1984 Jul;8(3):191-5.

PMID:
6086235
29.

Acute autonomic neuropathy.

Rubenstein AE, Gudesblatt MS, Mytilineou C, Yahr MD.

Int J Neurol. 1981;15(3-4):279-92. Review. No abstract available.

PMID:
6765481

Supplemental Content

Loading ...
Support Center